Archives for June 15, 2003

← 2003

Martek gets last of major formula makers under its belt

Martek Biosciences says it has signed a worldwide license agreement with Nestec, the Nestle affiliate, for Martek's technology relating to docosahexaenoic acid (DHA) and arachidonic acid (ARA) in infant formulas.

Unigen ups European distribution

US plant extract company Unigen Pharmaceuticals has signed new distribution agreements with six partners in Europe and Latin America, expanding its sales presence in international markets.

FTC pulls up HeartBar marketers for deceptive claims

Unither Pharma and United Therapeutics Corporation have agreed to settle Federal Trade Commission (FTC) charges that they made deceptive claims in advertising for their HeartBar product, reported the FTC.

Liquorice plant may offer SARS treatment

A compound found in the root of the liquorice plant could be more effective at treating the SARS virus than currently used drugs, reported researchers from the Institute of Medical Virology at Frankfurt University Medical School in this week's Lancet.

GMO compliance to enter global stage

A global agreement to protect biodiversity and human health moved one step further on Friday when Environment Ministers in the EU formally adopted the regulation on the trans-boundary movements of genetically modified organisms (GMOs).

Diabetes continues to rise

One in three Americans born in 2000 will develop diabetes, according to a US Centers for Disease Control and Prevention (CDC) report presented last week.

Health claim for lycopene?

American Longevity has filed a health claim petition with the Food and Drug Administration requesting that it allows the use of certain dietary supplement health claims for lycopene, tomatoes, tomato-based products, and cancer.